Lula said that Brazil will respond with the Law of Economic Reciprocity– a legal framework enacted in 2025 that allows the country to respond proportionately to unilateral trade, investment, or ...

Investing.com -- Britain and France have agreed to order more Storm Shadow cruise missiles and accelerate work on developing a replacement system as part of a refreshed defense agreement.

It touched a record peak of $111,988.90 and was last up 0.4% at $111,259. Since the beginning of the year, bitcoin has advanced more than 18%. " Bitcoin is the only asset I am aware of where it ...

AWS developed its custom-built infrastructure solution—the In-Row Heat Exchanger (IRHX)—instead of adopting widespread industry-standard liquid cooling solutions. This approach allows AWS to ...

Investing.com -- Fitch Ratings has downgraded Polaris (NYSE: PII) Inc.’s Long-Term Issuer Default Rating and senior unsecured notes rating to ’BBB-’ from ’BBB’, with a Negative outlook.

U.S. stock indexes were buoyed on Wednesday by AI confidence thanks to Nvidia, which became the first company to reach a market cap of $4 trillion.

Investing.com -- Costco Wholesale (NASDAQ: COST) stock rose 1% after the warehouse retailer reported an 8% increase in net sales for June, showing continued strong consumer demand.

For fiscal year 2026, AZZ provided guidance of $5.75-$6.25 for adjusted EPS, compared to the analyst consensus of $5.88. The company expects revenue between $1.63-1.73 billion, in line with the ...

Investing.com -- A Meta Platforms (NASDAQ: META) research scientist has delivered a harsh critique of the company’s ...

Investing.com -- Nurix Therapeutics Inc (NASDAQ: NRIX) reported better-than-expected financial results for its fiscal second quarter ended May 31, 2025, driven by significant milestone payments from ...

Investing.com -- AGCO Corporation (NYSE: AGCO) stock rose 2.7% after the agricultural machinery manufacturer announced a new $1 billion share repurchase program.

Investing.com -- Ultragenyx Pharmaceutical (TADAWUL: 2070) Inc. (NASDAQ: RARE) stock plummeted 33% after the company announced its Phase 3 Orbit study for UX143 (setrusumab) in osteogenesis imperfecta ...